C07D 239/545
With other hetero atoms or with carbon atoms having three bonds to
Official title: with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
C07D239/545 (With other hetero atoms or with carbon atoms having three bonds to) appears on 459 US grants and 330 published applications in this corpus.
Search patents in C07D- Granted patents
- 459
- Published applications
- 330
- Assignees
- 300
- Inventors
- 1,524
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 8 | 0 |
| 1977 | 7 | 0 |
| 1978 | 12 | 0 |
| 1979 | 0 | 0 |
| 1980 | 6 | 0 |
| 1981 | 9 | 0 |
| 1982 | 8 | 0 |
| 1983 | 8 | 0 |
| 1984 | 10 | 0 |
| 1985 | 14 | 0 |
| 1986 | 8 | 0 |
| 1987 | 10 | 0 |
| 1988 | 9 | 0 |
| 1989 | 16 | 0 |
| 1990 | 10 | 0 |
| 1991 | 10 | 0 |
| 1992 | 13 | 0 |
| 1993 | 11 | 0 |
| 1994 | 8 | 0 |
| 1995 | 7 | 0 |
| 1996 | 8 | 0 |
| 1997 | 9 | 0 |
| 1998 | 6 | 0 |
| 1999 | 5 | 0 |
| 2000 | 12 | 0 |
| 2001 | 16 | 0 |
| 2002 | 12 | 10 |
| 2003 | 10 | 17 |
| 2004 | 8 | 15 |
| 2005 | 6 | 16 |
| 2006 | 9 | 17 |
| 2007 | 8 | 14 |
| 2008 | 6 | 15 |
| 2009 | 7 | 9 |
| 2010 | 8 | 13 |
| 2011 | 6 | 9 |
| 2012 | 16 | 14 |
| 2013 | 10 | 15 |
| 2014 | 9 | 9 |
| 2015 | 16 | 14 |
| 2016 | 10 | 16 |
| 2017 | 10 | 19 |
| 2018 | 13 | 18 |
| 2019 | 13 | 12 |
| 2020 | 12 | 12 |
| 2021 | 3 | 11 |
| 2022 | 12 | 17 |
| 2023 | 3 | 8 |
| 2024 | 6 | 12 |
| 2025 | 4 | 12 |
| 2026 | 2 | 6 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Prodrugs for sustained releasing therapeutic agents and uses thereof8 Sep 2026US 12,729,186 B2Liangjiang Medicine Co., Ltd.
- Triaryl compounds for treatment of PD-L1 diseases27 Jan 2026US 12,533,354 B2ChemoCentryx, Inc.
- Small molecule PARG inhibitors and methods of use thereof9 Dec 2025US 12,491,188 B2Board of Regents, The University of Texas System
- Uracil derivatives for stimulating read-through of premature termination codons2 Dec 2025US 12,486,254 B2Southern Research Institute
- Solid state forms of mavacamten and process for preparation thereof25 Mar 2025US 12,258,320 B2Assia Chemical Industries Ltd.
- Methods and compositions for prevention of anaphylaxis20 Aug 2026US 2026/0242369 A1Baylor College of Medicine
- Crystalline forms of tenofovir alafenamide6 Aug 2026US 2026/0226087 A1Gilead Sciences, Inc.
- Gpr35 modulators30 Jul 2026US 2026/0216198 A1ThirtyFiveBio Limited
- Anticancer drug conjugates4 Jun 2026US 2026/0151413 A1Ariel Scientific Innovations Ltd.
- Crystalline salt forms of n-((1-(2-(tert-butylamino)-2-oxoethyl)piperidin-4-yl) methyl)-3-chloro-5-fluorobenzamide and methods of use thereof2 Apr 2026US 2026/0092037 A1Praxis Precision Medicines, Inc.
Most cited
By later US patents
- Compounds for inhibition of ceramide-mediated signal transduction117US 6,323,201 B1The Regents of the University of California · 2001
- 5-Fluorouracil derivatives103US 4,336,381 AShionogi & Co., Ltd. · 1982
- Compounds for inhibition of ceramide-mediated signal transduction96US 6,562,819 B2The Regents of the University of California · 2003
- 3-Aryluracils having an ether (thio) carbomyloxy or sulphomyloxy substituent on the aromatic moiety66US 4,859,229 AHoffmann-La Roche Inc. · 1989
- Pyrimidine or triazine derivatives and herbicides58US 5,527,763 AIhara Chemical Industry Co., Ltd. · 1996